Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Nueva Ecija Cardiovascular Risk Experiment: An Evaluation of the Impact of Risk Information and Screening on Primary Prevention of Cardiovascular Disease

NCT03512691 is registered in ClinicalTrials.gov with UPecon Foundation, Inc. as lead sponsor.

NCT NCT03512691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03512691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Nueva Ecija Cardiovascular Risk Experiment: An Evaluation of the Impact of Risk Information and Screening on Primary Prevention of Cardiovascular Disease
Lead sponsor
UPecon Foundation, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 20, 2018
Completion date
December 31, 2021
Enrollment
5,019 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cardiovascular risk factor